檢索結果 - Mathilde Jalving
- Showing 1 - 9 results of 9
-
1
-
2
-
3
Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort 由 Sonja Levy, Dirk Grünhagen, Maureen J B Aarts, Ferry A L M Eskens, Kristien B M I Keymeulen, Lukas B Been, Alexander van Akkooi, Mathilde Jalving, Margot E T Tesselaar
發表在 Journal for ImmunoTherapy of Cancer (2020-10-01)獲取全文
Article -
4
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer 由 Arkajyoti Bhattacharya, Thijs S Stutvoet, Mirela Perla, Stefan Loipfinger, Mathilde Jalving, Anna KL Reyners, Paola D Vermeer, Ronny Drapkin, Marco de Bruyn, Elisabeth GE de Vries, Steven de Jong, Rudolf SN Fehrmann
發表在 eLife (2025-05-01)獲取全文
Article -
5
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment 由 Melanie M van der Klauw, T Jeroen N Hiltermann, Mathilde Jalving, Emoke Racz, Sjoukje Oosting, Anna K L Reyners, Wellington Candido, Annemarie Cecile Eggen, Ingeborg Bosma, Reinate D Horinga, Kelly C van Heuvelen, Janine Nuver
發表在 Journal for ImmunoTherapy of Cancer (2025-03-01)獲取全文
Article -
6
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation 由 Christos E. Zois, Anne M. Hendriks, Syed Haider, Elisabete Pires, Esther Bridges, Dimitra Kalamida, Dimitrios Voukantsis, B. Christoffer Lagerholm, Rudolf S. N. Fehrmann, Wilfred F. A. den Dunnen, Andrei I. Tarasov, Otto Baba, John Morris, Francesca M. Buffa, James S. O. McCullagh, Mathilde Jalving, Adrian L. Harris
發表在 Cell Death and Disease (2022-06-01)獲取全文
Article -
7
Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol 由 Phyllis van der Ploeg, Cynthia SE. Hendrikse, Anna MJ. Thijs, Hans M. Westgeest, Huberdina PM. Smedts, M Caroline Vos, Mathilde Jalving, Christianne AR. Lok, Ingrid A. Boere, Maaike APC. van Ham, Petronella B. Ottevanger, Anneke M. Westermann, Constantijne H. Mom, Roy I. Lalisang, Sandrina Lambrechts, Ruud LM. Bekkers, Jurgen MJ. Piek
發表在 Heliyon (2024-01-01)獲取全文
Article -
8
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study 由 Anneke L. Eerkens, Koen Brummel, Annegé Vledder, Sterre T. Paijens, Marta Requesens, Dominik Loiero, Nienke van Rooij, Annechien Plat, Floris-Jan Haan, Patty Klok, Refika Yigit, Thijs Roelofsen, Natascha M. de Lange, Rie Klomp, David Church, Arja ter Elst, René Wardenaar, Diana Spierings, Floris Foijer, Viktor Hendrik Koelzer, Tjalling Bosse, Joost Bart, Mathilde Jalving, Anna K. L. Reyners, Marco de Bruyn, Hans W. Nijman
發表在 Nature Communications (2024-09-01)獲取全文
Article -
9
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolResearch in context 由 Karlijn Verkerk, Birgit S. Geurts, Laurien J. Zeverijn, Vincent van der Noort, Henk M.W. Verheul, John B.A.G. Haanen, Astrid A.M. van der Veldt, Ferry A.L.M. Eskens, Maureen J.B. Aarts, Carla M.L. van Herpen, Mathilde Jalving, Jourik A. Gietema, Lot A. Devriese, Mariette Labots, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Egbert F. Smit, Haiko J. Bloemendal
發表在 The Lancet Regional Health. Europe (2024-04-01)獲取全文
Article
